Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study.

PLoS One · 2015 · PMC4684295 · PMID 26683302

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Comparison of hyperuricemic patients who did not use ULT (HUA /No gout /No ULT), to the matched reference group (No HUA /No gout /No ULT) showed a marginally significant effect on all-cause mortality (adjusted HR 1.24; 95% confidence interval (CI) 0.97–1.59) due to attrition of case number after matching procedure, and a significant risk of hyperuricemia for CVD mortality (adjusted HR 2.13; 95% CI 1.34–3.39) ( Table 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.